Skip to the page

Data / Form D filings / Cosmos Pharmaceuticals, Inc.

Cosmos Pharmaceuticals, Inc.: Form D filings

Cosmos Pharmaceuticals, Inc., a health care company in Middletown, DE, filed 3 Form D notices with the SEC between 2021 and 2025. The latest, on October 7, 2025, reports $750,000 sold of a $1.3 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
537 WHEELMEN STREET, Middletown, DE, 19709
Phone
(302) 563-0047
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1845816

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 7, 2025New notice$1,250,000$750,000$500,00014Sep 22, 2025sec.gov
Jun 3, 2022New notice$300,000$175,000$125,0007May 31, 2022sec.gov
Feb 23, 2021New notice$250,000$225,000$25,0007Dec 8, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Joseph W. WhiteExecutive Officer, Director
Alexander M. ColtonExecutive Officer, Director
Philip W. McBrideExecutive Officer
Bart W. EdmundsDirector
Christian W. ColtonDirector

Other health care companies in Delaware that filed recently

Every Form D from the week of Oct 6, 2025 · All recent filings in Delaware · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Cosmos Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.